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Dear editor,
First, we would like to thank the editorial board for the interest
in our study and the thorough and extensive commentary [18]
to our publication, “The impact of provider surgical volumes
on survival in children with primary tumours of the central
nervous system—a population-based study” [48]. The
editorial includes comments on central publications and
addresses some of the problems with the available evidence
concerning the volume-outcome relationship. We appreciate
the opportunity to comment further on the argumentation for
and against centralization of paediatric neurosurgery. If a
surgeon does not practice surgery, he or she will not master
the procedures. This is self-evident. This is why training and
licensing is required to become specialists and subspecialists.
Although, accepting a volume-outcome relationship, there
are still many unanswered questions as to what to gain from
centralisation of different neurosurgical procedures. Here, we
would like to expand the literary review in the editorial and
comment on the specific points in respect to our study.
The magnitude and importance of the volume-outcome
relationship is difficult to assess from a review of the
available literature. Major limitations rise from the fact that
the data source are mainly American administrative claims
databases or discharge summaries of variable quality that
do not contain much clinical data. Usually, such record data
only allow for crude adjustments for age, sex, ethnicity,
hospital size and socioeconomic status [often just assessed
as mean income in the postal code of the patient’s
residential address (!)]. The severity and incidence of the
treated disease is not corrected for, and there are often
considerable limitations in data concerning differences in
referral and case mix [28, 29]. It should further be
remembered that high volume institutions in the USA more
often treat younger patients, whites, patients with private
insurance and residents of wealthier areas. Hospitals with
the highest volumes typically also have more elective cases.
In publications based on American administrative data-
bases, the main outcome is usually surgical mortality,
measured as in-house-mortality. Although 30-day mortality
has a better face validity, the correlation to in-house mortality
rates are generally at least moderate (kappa>0.40), but with
variance across conditions [14]. Surgical mortality has in the
USA been endorsed as an Inpatient Quality Indicator (IQI)
by the Agency for Healthcare Research and Quality in
eight surgical procedures for adults, including craniotomies
(the other seven are specific surgical procedures, while
craniotomy is the opening of a body part). The line of logic
is that since (1) surgical mortality in craniotomies is defined as
a quality indicator, and (2) surgical mortality in many
publications is lower in high-volume providers of care, then
(3) surgical volume is a quality indicator (quod erat
demonstrandum). However, studies by the Veterans Affair
(VA) National Surgical Quality Improvement Program
(NSQIP), which prospectively collects clinical data on all
major surgical operations in the VA, do not reach the same
conclusions as studies based on administrative claims data:
“Unlike retrospective studies that are based on administrative
databases, NSQIP studies have failed to demonstrate a direct
relationship between volume and risk-adjusted outcomes of
surgery across various specialties. These studies have empha-
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sized that the quality of systems of care was more important
than volume in determining the overall quality of surgical care
at an institution. High-volume hospitals could still deliver
poor care in as much as low-volume hospitals could deliver
good care. NSQIP studies have also underscored the major
limitations of claims data and administrative databases in the
provision of adequate risk-adjustment models that are crucial
for volume-outcome studies” [35].
What is known about the volume-outcome relationship
in neurosurgical tumour operations?
There are ten publications that specifically address the
effect of provider volume in various neurosurgical tumour
operations [3, 5–7, 22, 25, 26, 38, 45, 48], nine of which
are North American, and six of them involve the same
author. As far as we are aware, there are only two
publications, including ours, that assess long-term survival
in relation to provider volumes [26, 48]. The Canadian
study from Ontario 1977–1987 [26] and our study [48]
reached opposite conclusions. Since surgical mortality is
the main outcome parameter of the American studies, it
would be of interest to know if perioperative mortality is
indicative of overall treatment results. The overall prognosis
of the disease is likely a strong predictor, since the 30-day
mortality rate is merely the intonation of the Kaplan-Meier
curve. This is presumably why simple biopsies are associated
with a higher incidence of perioperative death than craniot-
omies [36]. The patient selection is likely crucial for such
early outcomes, as severe adverse events leading to early
death due to the surgical handiwork itself are exceedingly
rare. In some publications, the observed difference has been
between academic centres (teaching hospitals) and smaller
non-academic centres [26, 38], while in others the teaching
status of the hospitals was not specified. However, in many
countries (including Norway), neurosurgery is not performed
outside university hospitals.
Higher-volume providers are in one study reported to
have superior short-term outcomes after surgical resection
of malignant intracranial tumours. Surgical mortality for
very low-volume to very high-volume hospitals were as
follows: 3.8, 3.2, 2.4, and 1.8%. The numeric thresholds for
hospital volumes were 1–84 cases per year (very low), 85–
147 cases per year (low), 148–292 cases per year (high),
and more than 292 cases per year (very high). For surgeon
volume, the thresholds were 1–6 cases per year (very low),
7–11 cases per year (low), 12–21 cases per year (high), and
more than 21 cases per year (very high) [22]. US data from
the Nationwide Inpatient Sample (NIS) suggested that
higher-volume hospitals and surgeons provide superior
short-term outcomes after transsphenoidal pituitary tumour
surgery with shorter lengths of stay [7]. However, 64% of
the hospitals treated only 1–4 cases annually and 55% of
surgeons treated only one patient annually. The median
annual case load per surgeon in the US data was only three
admissions. For acoustic neurinomas, higher-volume hospitals
and higher volume surgeons were associated with superior
short-term outcomes with shorter lengths of stay, however at no
significant difference in perioperative mortality rates [5]. The
surgical mortality and adverse hospital discharge rates were
reported to be lower when meningioma surgery was
performed by high-volume providers [25]. However, 51% of
the treating hospitals only operated on one to three meningi-
omas annually and 48% of the surgeons in the study only
operated on one meningioma per year. In metastatic brain
tumours, it was also found that higher-volume hospitals and
surgeons provided superior short-term outcomes, with shorter
lengths of stay and a trend towards lower charges [3].
However, 41% of the hospitals operated on only one to two
metastatic brain tumours per year and 50% of the surgeons
operated on only one metastatic tumour annually. Perioper-
ative mortality was lower when craniotomies in children
were performed at high-volume hospitals and by high-volume
surgeons in the United States, from 1988 to 2000 [45].
However, 68% of the hospitals treated only one to four
paediatric brain tumours annually and 66% of the surgeons
operated on only one paediatric case per year. Thus,
low-volume institutions in the USA have much lower
volumes than Norwegian and probably most European
centres. The relevance of these findings to countries where
healthcare is organized differently and where caseloads are
higher remains unclear.
What about other neurosurgical procedures?
In the USA, complications after microvascular decompression
(the Jeanetta procedure) were less frequent after surgery
performed at high-volume hospitals or by high-volume
surgeons. However, surgical volumes and mortality rates were
not significantly related [33]. Sixty-eight percent of the
American hospitals studied treated only one to two patients
annually. American high-volume hospitals also had superior
short-term outcomes in surgical treatment of Parkinson
disease (both thalamotomies and deep-brain stimulation) [27].
In a US study of patients with unruptured aneurysms
treated from 1996 to 2000, treatment at high-volume
institutions or by high volume physicians was associated
with significantly lower morbidity rates and modestly lower
mortality rates [4, 31]. However, in 64% of the hospitals,
the annual volume of clipped elective aneurysms was only
one to three cases. Another study reports that US patients
with a diagnosis of subarachnoid haemorrhage (SAH) on
the discharge records, who initially presented through the
emergency department of a hospital with a high volume of
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SAH cases, had significantly lower mortality rates [24]. In
California, hospitals that treated more patients with SAH
had substantially lower rates of in-hospital mortality [2]. In
New York, hospitals that frequently perform aneurysm
operations had lower mortality rates for patients undergoing
craniotomy for cerebral aneurysm than hospitals that
performed fewer operations [8, 49]. It has also been
reported that very-low-volume hospitals in the USA are
associated with higher mortality rates than very-high-
volume hospitals for both emergency and elective aneurysm
surgery [23]. A study from California and New York
suggested that mortality rates in older patients who are
treated surgically for SAH may be inversely correlated with
the annual number of craniotomies performed for SAH in
patients 65 years of age or older at a given institution [50].
An American single-institution study in unruptured aneur-
ysms also found that the surgeon’s experience was a
predictor of functional outcome [19]. Conversely, Japanese
and English studies, and one American study [32] about
surgical volumes in SAH found no mortality difference
after correcting for confounders [30, 42, 52]. Despite
different degrees of centralization and healthcare organisation,
the outcome after SAH does not seem to differ from
country to country [37].
A relationship between surgeon experience and shunt
complications was seen in some studies [13, 20, 41] but
not in others [34, 43]. In the USA, paediatric shunt
procedures performed at high-volume hospitals or by
high-volume surgeons were associated with lower in-
hospital mortality rates [46]. Some have speculated that
the arrival of new interns and residents at teaching
hospitals each July might cause an annual transient
increase in poor patient outcomes and inefficient care.
There was, however, no evidence that brain tumour or
shunt surgery performed in paediatric patients at US
teaching hospitals during July and August is associated
with more frequent adverse patient outcome or inefficient
care than similar surgery performed during other months
[47]. It, therefore, seems unclear if hydrocephalus (the by
far most prevalent condition in paediatric neurosurgery)
will profit on centralized care.
What is low?
The nature of the learning curve in surgery is not
fully understood. It is so far unclear whether the
relationship between volume and outcome is continuous,
step-wise, or has a single clear cut-off [17]. Therefore,
the necessary degree of centralization to obtain a potential
or optimal benefit is not known; being either local,
regional, national, or even international. The definitions
of high-volume and low-volume are relative. As seen in
the review of the available literature, the provider volumes
of the low-volume centres are often extremely low, at least
by Norwegian standards.
Surgeon volume or hospital volume?
Institutional volumes are not necessarily related to the
caseload of the individual surgeons. Larger institutional
volumes do not only attract more difficult cases, but also
proportionally as many easy operations, out-patient con-
sultations and non-surgical work. To deal with the higher
workload, there are naturally more physicians. Often the
staff-to-patient ratio may be higher in larger institutions.
The number of hours in the operating room (OR) per week
per surgeon is, therefore, presumably not higher in high-
volume institutions. The volume of difficult cases per
surgeon depends much on the organization, thus the ability
to choose the right surgeon for the right job (i.e. the system
of care). It is our belief that it is possible to achieve high
volumes of difficult procedures (with transferable) skills for
selected surgeons also in smaller centres.
The focus in debates about centralization is usually
institutional volumes. For many procedures, the observed
associations between hospital volume and operative mortality
is no longer found if adjusting for surgeons volumes [12]. But
even among high-volume surgeons there may be significant
differences in patient outcome [9, 10]. As also acknowledged
by the editorial, there are differences between surgeons with
respect to talent. Both talent and professional interests may
relate much to the final skills of the surgeon. Surgeons with
academic positions are therefore not necessarily inferior,
even though they may spend less time in the OR. Further,
the systems care outside the OR, and the ability to follow
guidelines and evidence-based practice of care and patient
selection may play an important role for the final outcome. A
department’s ability to select the right personnel for the right
job is depending on leadership and organization, and likely
not institutional volume.
What about clinical experience?
Years of clinical experience has presumably a positive
effect, if to believe in a simple volume-outcome relation-
ship. Nevertheless, it has been seen that for some complex
procedures, older surgeons have higher operative mortality
rates than their younger colleagues [51]. A systematic
review on the importance of medical knowledge and
healthcare quality to years in practice and physician age
concluded that “physicians who have been in practice
longer may be at risk for providing lower-quality care”
[16]. Although, many are ready to centralize surgical
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procedures based on the available low evidence data (with
many outliers), few are ready to degrade experienced
surgeons because of a similar statistical relationship. We
believe such findings nevertheless further emphasize the
importance of selecting the right physician for the right job,
regardless of age and case volume.
What is the cost-benefit of centralization?
For neurosurgical procedures, this is not known. A population-
based study of 243,000 patients who underwent abdominal
aortic aneurysm surgery, cororary by-pass surgery or coronary
angioplasty in California compared different regionalization
strategies. The authors concluded that “selective referral to high
volume centers may, at best, yield only modest improvement in
outcomes but would result in massive disruption in hospital
services in California, and possibly in other decentralized
health care environments. Selective avoidance of low volume
hospitals would not lead to any improvement in outcomes…
The use of procedure volume as the basis for evidence-based
hospital referrals should be re-evaluated by all stake-holders
before undertaking further efforts to regionalize healthcare
delivery using volume-based referral strategies” [28]. The
cost-benefit of centralization depends on the type of
procedure, on how healthcare is organized, and the geo-
graphical and organizational challenges involved. A benefit
of centralization of paediatric neurosurgery is questionable
due to scarce and conflicting evidence. At the present,
centralization in Norway would also possibly yield negative
consequences in terms of survival for some patients [48]. For
complex treatments that require extensive multidisciplinary
and designated teams (such as certain types of craniofacial
and epilepsy surgery) or special and expensive equipment
(such as a stereotactic radiosurgery), the benefits of
centralization are much easier to perceive.
Centralization of (all) paediatric neurosurgical procedures,
as suggested by the editorial would have a major expense in
terms of costs due to patient logistics and transportation (the
distance from the northernmost part of Norway to Oslo is close
to 2,000 km). Centralization would also increase the social
burden of disease by separating parents, siblings and patients
from their local environment to receive routine check-ups, in
times of crisis or during long-lasting treatments. Also to be
remembered, complications are quite frequent after discharge
following various neurosurgical procedures. This may be
especially important in paediatric neurosurgery as, for instance,
hydrocephalus, infratentorial surgery or myelomeningoceles
are associated with a certain frequency of cerebrospinal fluid
leaks, shunt malfunction or infections. Complications are best
handled by the operating surgeon, who has all the information
and knowledge about the very patient, and who feels personal
responsibility for the outcome. Even today (without much
centralisation), such neurosurgical patients may be admitted to
general medical or surgical wards in their local hospitals, if
distance to the neurosurgical department is too long. Here, their
condition and their symptoms may frequently be misinter-
preted. Our experience is that longer delays in treatment and
more nihilistic approaches are seen if patients are not under the
direct care of the responsible neurosurgeon. The mentioned
side-effects of centralization may naturally be fewer in smaller
and more densely populated countries. We agree with the
editorial that “other outcomes, such as quality of life, may well
be more important in this debate than mortality”, but we find it
unlikely that separation of families, longer distances, longer
chains of referral and probably longer doctors’ delays will
effect quality of life positively.
Is paediatric neurosurgery special?
Based on the available evidence, it is hard to understand why
paediatric neurosurgery is singled out as a field that likely will
profit from centralization. Based on the scarce evidence
available, just as strong (or stronger) arguments may be used
for (most) other neurosurgical (and even medical) entities.
There are many rare entities in most fields of neurosurgery,
and paediatric brain tumours are not special in this respect.
Although a fairly small speciality in number of surgeons,
neurosurgery is a very diverse speciality involved in a wide
range of different procedures. This is different from many
other surgical specialities that are dominated by a few,
frequent, and quite standardized procedures (e.g. coronary
bypass surgery, hip replacements, cholecystectomies, etc.).
The learning curves of neurosurgical procedures are, there-
fore, probably more complex to assess, understand and
predict. There are also few standardized neurosurgical
procedures and treatment guidelines. Therefore, indications,
approaches, techniques and preferred technical aids may vary
much from surgeon to surgeon and from centre to centre.
There are around 130 different subtypes of primary central
nervous system tumours [40], often with large variations in
location, size and involvement of adjacent neurovascular
structures. Although the adult tumour population is somewhat
different from the paediatric tumour population (as pointed
out in the editorial), most of the time a neurosurgeon has to
rely on transferable skills, since the likelihood of operating the
exact same entity with the exact same shape and location may
be slim in many cases.
Is surgery special?
Many believe that, due to its practical nature, surgery is
special in respect to the volume-outcome relationship. Both
volume and outcome may be easier to measure in surgery,
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but seeming volume-outcome relationships have been
observed in a broad range of medical settings, including
sepsis treatment [15], testicular cancer [21], pulmonary
embolism [1], peptic ulcers [39] and ischaemic stroke [44],
among others. Thus, the arguments for centralization in
neurosurgery may be just as strong or weak for a range of
non-surgical procedures.
Is there enough evidence to support centralization?
So far, this is unfortunately a question of faith; but the
editors are clearly believers. Available evidence is
scarce and frequently associated with major methodo-
logical flaws and confirmation bias. Based on the
available evidence, it is impossible to quantify and
foresee the effects of centralization, and the cost-benefit
therefore remains a division of unknowns. What can
then be learned? Although impractical to utilize on a
national level, the evidence for centralization to certain
surgeons seems higher than to certain institutions—as long
as surgeons are not too old (!). The selection of the right
surgeon for the right job is utterly important. This can be a
focus in all neurosurgical centres, regardless of institutional
volumes. It is not documented that paediatric neurosurgery is
special in respect to potential benefits of centralization, but
tolls for such patients and their families would likely be higher
than in adults. A systematic review on the volume-outcome-
relationship in cancer surgery concluded that most studies are
not robust enough to support major policy decisions [11].
Another investigation on the methods of the available
volume outcome research concluded that: “Volume offers
an easy, simple measure that can be easily understood and
employed by both healthcare providers and consumers.
However, the use of volume as a quality indicator is not as
straightforward as it may seem… In the meantime, it seems
premature to be moving forward with referrals based on
volume alone when there are still many issues to be resolved.
We strongly support the profession, the consumers, and the
purchasers of healthcare for their desire to truly understand
high quality health care, but we also caution against
oversimplified solutions that do not accurately address those
concerns” [17].
Weaknesses in our study
The editorial points at five specific weaknesses in our
study. Some of them are already discussed in the paper.
1. The low number of operations in Norway (risk of
type II statistical error): as acknowledged in the
paper, this potential power problem is not solvable,
as the paper included all operated tumours. However,
the potential power problem is not a concern for the
subgroup where a statistical difference was observed
[primitive neuroectodermal tumours (PNETs)/medul-
loblastomas]. The editorial also speculates if surgeon
volumes were small at even the largest centre. To be
remembered, the study included only first time
operations for central nervous system tumours, and
the numbers do not reflect the total number of
craniotomies. As already mentioned, there is no
agreement on what is small and what is not. Our
findings may not necessarily apply to centres where
volumes are different, training is less uniform or
healthcare is differently organized.
2. There were statistical imbalances in the distribution of
some tumour entities, in particular choroid plexus
tumours. As acknowledged in our paper, we cannot
explain this finding, but lack of a central histopatho-
logical review (which is unrealistic in studies of this
magnitude) may allow for some differences in classi-
fication. There may also be differences in reporting.
As choroid plexus tumours are most frequently
benign, the higher percentage operated in the larger
centre, would unlikely alter the results in favour of
the higher volume centre.
3. One hundred and twenty-seven patients were excluded,
as they harboured lesions which were not histologically
confirmed. The editorial asks for a better description of
these patients. This is likely a heterogenous group
ranging from benign, subclinical lesions like Rathke’s
cleft cycts and incidental dysembryoplastic neuro-
epithelial tumours (DNETs) to highly malignant pons
gliomas. (Biopsies of mid brain gliomas have not
routinely been carried out in Norway). There was no
significant difference in survival between geograph-
ical health regions for this heterogenous group of
127 patients: 78% 5-year survival (low-volume
regions) vs 66% 5-year survival (high-volume re-
gion) (p=0.31). Thus, a potential selection bias in
relation to this group does not alter the conclusion of
our paper. The study only included tumours that were
histologically confirmed. When histopathology was
available at a later stage (e.g. after a wait-and-can
approach), survival was measured from date of
surgery. Tumours that were only histologically con-
firmed post-mortem were not included in our analyses
(three cases).
4. The editors speculate that some of the difference
attributable to variations between centres in respect to
PNETs/medulloblastomas may be due to differences in
the management of relapse. This may be one of several
possible explanations. However, we have no information
on how relapsing disease was treated in the different
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regions. Regardless of cause, we find the difference in
survival disturbing.
5. Insufficient information was given regarding “set-up”
of paediatric neurosurgery in Norway. A national
review on individual caseloads of Norwegian neuro-
surgeons found the caseload of tumours per surgeon to
be quite similar across centres (despite differences in
institutional volumes). In the high-volume centre, there
is a separate bed ward for paediatric surgery, served by a
team of designated paediatric neurosurgeons. In the other
centres, paediatric neurosurgery is handled by one or two
responsible surgeons that for the most part serve adults.
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